ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1108

Protein Citrullinations By PAD Enzymes Promote Dendritic Cell Transdifferentiation into Osteoclast and Generate Targets for RA-Specific Antibodies

Akilan Krishnamurthy1, Jimmy Ytterberg2, Meng Sun1, Vijay Joshua1, Heidi Wähämaa1, Nataliya Tarasova2, Khaled Amara1, Johanna Steen1, Vivianne Malmström1, Bence Rethi1 and Anca I Catrina1, 1Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 2Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: ACPA, dendritic cells and osteoclastogenesis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Biology and Pathology of Bone and Joint - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Immature dendritic cells (DCs) can develop into osteoclasts (OCs), however, the mechanisms regulating this differentiation switch are not yet understood. We have shown that protein citrullination can play important roles in OC differentiation, both at steady state and in rheumatoid arthritis (RA) when anti-citrulline protein antibodies (ACPAs) induce bone erosion through an IL-8 mediated induction of OC development. In the present study we analyzed how protein citrullination and ACPAs regulate differentiation plasticity towards the OC lineage in DCs.

Methods: We have previously shown that the endogenously produced lactic acid (LA), a glycolysis side product, can increase the ability of developing DCs to differentiate into osteoclasts in dense cell cultures, whereas sparse cultures, associated with low LA levels, promoted the development of immunostimulatory DCs with little ability to form OCs. By exploiting this mechanism we generated different monocyte-derived DC types in parallel with macrophages and cultured these cells in presence of M-CSF and RANKL to induce OC development. Mass spectrometry was applied to analyze protein expression and citrullination at different stages of OC differentiation. Activity of peptidylarginine deiminases, the enzymes responsible for protein citrullination, was measured by ELISA, cytokine levels were analyzed using CBA technology. We studied in detail the autocrine effects of IL-8 in OC cultures.

Results: Citrullinated-actin peptides were identified in all stages DC-OC transdifferentiation and citrullinated-vimentin peptides were identified in mature OCs. Expression of PAD2 and PAD4 increased during DC differentiation and PAD activity was detected in both DCs and OCs. Interestingly, the efficiency of DC-OC transdifferentiation correlated with the level of PAD activity and with higher detection of citrullinated peptides in DCs. The PAD inhibitor Cl-Amidine efficiently interfered with OC development form DC precursors. Polyclonal and certain monoclonal ACPAs increased osteoclastogenesis from DCs and the intensity bone resorption. DC-derived OC differentiation was inhibited by Cl-Amidine in the presence of ACPAs. The IL-8 receptors CXCR1 and CXCR2 were present on immature DCs and the increased osteoclastogenesis was associated with elevated IL-8 levels in ACPA-treated cultures. IL-8 neutralization blocked the ACPA-mediated increase of OC development.

Conclusion: Our results indicated that DCs are heterogenic in their ability to form OCs and the differentiation plasticity towards the OC lineage might be influenced by protein citrullination. The increase of LA at sites of immune activation might play an important role in the reprogramming DCs and increasing OC development. Antibodies that target citrullinated proteins and have been suggested to play an improtant pathogenic role in RA-associated bone destruction ACPAs can further increase osteoclastogenesis from DCs through an IL-8 dependent mechanism, which further support OC development in an autocrine manner. Blocking IL-8 and PAD activities represent important therapeutic possibilities that might interfere with DC transdifferentiation into OC and ACPA-induced bone damage.


Disclosure: A. Krishnamurthy, None; J. Ytterberg, None; M. Sun, None; V. Joshua, None; H. Wähämaa, None; N. Tarasova, None; K. Amara, None; J. Steen, None; V. Malmström, None; B. Rethi, None; A. I. Catrina, None.

To cite this abstract in AMA style:

Krishnamurthy A, Ytterberg J, Sun M, Joshua V, Wähämaa H, Tarasova N, Amara K, Steen J, Malmström V, Rethi B, Catrina AI. Protein Citrullinations By PAD Enzymes Promote Dendritic Cell Transdifferentiation into Osteoclast and Generate Targets for RA-Specific Antibodies [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/protein-citrullinations-by-pad-enzymes-promote-dendritic-cell-transdifferentiation-into-osteoclast-and-generate-targets-for-ra-specific-antibodies/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/protein-citrullinations-by-pad-enzymes-promote-dendritic-cell-transdifferentiation-into-osteoclast-and-generate-targets-for-ra-specific-antibodies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology